Fostamatinib is a medication used to treat certain types of chronic immune system diseases, including chronic immune thrombocytopenia (ITP) and rheumatoid arthritis (RA). It is a Janus kinase (JAK) inhibitor, which means it works by blocking the action of certain proteins that play a role in inflammation and other immune system responses. It is taken in tablet form and can help reduce the symptoms of ITP and RA, such as fatigue, joint pain, and bruising. In some cases, it can also help increase platelet counts in people with ITP.
Fostamatinib is a medication used to treat a specific condition affecting your blood platelets. Here's a breakdown of its key features:
- Type of medication: Spleen Tyrosine Kinase (SYK) inhibitor
- Main use: Treats chronic immune thrombocytopenia (ITP) in adults after other treatments haven't been effective.
- What is ITP?: Chronic ITP is an autoimmune disorder where your immune system destroys platelets, leading to a low platelet count. Platelets are blood cells that help form clots to prevent bleeding.
How Fostamatinib Works:
- Fostamatinib targets and inhibits a protein called SYK in the spleen.
- By inhibiting SYK, it reduces the destruction of platelets by the immune system.
- This helps increase the number of platelets in your blood, reducing the risk of excessive bleeding.
Administration:
- Fostamatinib comes as tablets taken orally, typically twice a day.
Important to Remember:
- Fostamatinib is a prescription medication and should only be taken under a doctor's supervision.
- It's not a first-line treatment for ITP and is usually prescribed when other options haven't yielded sufficient results.
- There can be potential side effects associated with Fostamatinib, so be sure to discuss these with your doctor.
Additional Information:
- Fostamatinib is a relatively new medication, and further research is ongoing to understand its long-term effects.
- If you have any questions or concerns about Fostamatinib or ITP, consult your doctor for personalized advice.